| Findings in IC vs. OOC patients US, United States; B.C., British Columbia; UK, United Kingdom NCCN, | ||||||||
|---|---|---|---|---|---|---|---|---|
| Overall | In criteria | Out of criteria | ||||||
| Country/providence | Guideline | Total n of cohort | IC (% of total cohort) | OOC (% of total cohort) | Total PV IC (% of IC cohort) | Total PV OOC (% of OOC cohort) | High risk^ PVs (% of total PVs) | High risk^ PVs (% of total PVs) |
| U.S. | NCCN | 953 | 473 (49.6) | 480 (50.4) | 43 (9.1) | 40 (8.3) | 22 (26.5) | 8 (9.6) |
| Ontario | MOHLTC | 953 | 210 (22.0) | 743 (78.0) | 18 (8.6) | 65 (8.7) | 5 (6.0) | 25 (30.1) |
| B.C. | BCHCP | 953 | 203 (21.3) | 750 (78.7) | 24 (11.8) | 59 (7.9) | 9 (10.8) | 19 (22.9) |
| Australia | eviQ | 953 | 180 (18.9) | 773 (81.1) | 19 (10.6) | 64 (8.3) | 12 (14.5) | 18 (21.7) |
| U.K. | NICE* | 826** | 127 (14.7) | 736 (85.3) | 11 (8.7) | 64 (8.7) | 6 (7.2) | 22 (26.5) |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.